Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia

Background The main advantage of GeneXpert MTB/RIF ® (Xpert) molecular diagnostic technology is the rapid detection of M .tuberculosis DNA and mutations associated with rifampicin (RIF) resistance for timely initiation of appropriate treatment and, consequently, preventing further transmission of th...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	BMC infectious diseases Ročník 20; číslo 1; s. 1 - 9
Hlavní autori:	Ershova, Julia V., Volchenkov, Grigory V., Somova, Tatiana R., Kuznetsova, Tatiana A., Kaunetis, Natalia V., Kaminski, Dorothy, Demikhova, Olga V., Chernousova, Larisa N., Vasilyeva, Irina A., Kerr, Eleanor M., Cegielski, J. Peter, Kurbatova, Ekaterina V.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London BioMed Central 25.07.2020 BioMed Central Ltd Springer Nature B.V BMC
Predmet:	Clinical outcomes Diagnosis Diagnostic systems Disease transmission Drug resistance GeneXpert MTB/RIF Health services HIV Human immunodeficiency virus Imprisonment Infectious Diseases Internal Medicine Medical Microbiology Medical research Medicine Medicine & Public Health Mutation Parasitology Patient outcomes Patients Rank tests Research Article Rifampicin Rifampin Statistical analysis Survival analysis Tropical Medicine Tuberculosis Tuberculosis and other mycobacterial diseases Russia Drug resistance Rifampicin GeneXpert MTB/RIF
ISSN:	1471-2334, 1471-2334
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!